Quantum-Si Added to the Nasdaq Biotechnology Index

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI). The addition is based on the results of the annual reconstitution of the index announced by Nasdaq on December 10, […]

Quantum-Si Reports Third Quarter 2021 Financial Results

Quantum-Si Continues Momentum and Accelerates Commercialization Efforts GUILFORD, Conn., November 10. Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced financial results for the quarter ended September 30, 2021 and provided a business update. Recent Highlights Expanded Early Access program to ten, with […]

Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain

Acquisition expands Quantum-Si’s capabilities in semiconductor chip assembly and packaging GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique single molecule protein sequencing platform, today announced that it acquired Majelac Technologies LLC, a privately-owned company providing semiconductor packaging and integrated circuit assembly services. The acquisition secures […]

Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat […]

Quantum-Si to Report Third Quarter 2021 Financial Results on November 11, 2021

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq:QSI), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report third quarter 2021 financial results on November 11, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on November 11, […]

Quantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing Platform

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing […]

Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a company pioneering next-generation semiconductor chip-based proteomics, today announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 27-30, 2021. John Stark, Quantum-Si’s Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on […]

Quantum-Si Reports Second Quarter 2021 Financial Results

Quantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a company pioneering next-generation semiconductor chip-based proteomics, today announced financial results for the quarter ended June 30, 2021 and provided a business update. John Stark, Quantum-Si’s Chief Executive Officer, and Claudia Drayton, Quantum-Si’s Chief Financial Officer, […]

Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. […]

Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report second quarter 2021 financial results on August 12, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on August 12, 2021, […]